Navigation Links
Columbia Asia Referral Hospital, Yeshwanthpur, Successfully Conducts HOLEP to Treat a 72-Year-old With Urology Disorder
Date:2/17/2013

BANGALORE, February 18, 2013 /PRNewswire/ --

Columbia Asia Referral Hospital, Yeshwanthpur (CARHY) successfully conducted a Urology surgery through an advanced laser technology - HOLEP. The team of doctors led by Dr Manohar,  Consultant Urologist at CARHY removed a large prostate gland weighing 350 gms, hitherto unheard of in medical history.

"HOLEP by 100 Watt Holmuim Laser technique that was used to treat the 72-year-old is an advanced laser technology and is the latest treatment for all urological problems. The advantages of the HOLEP 100 watt laser technique are multiple. The usage of this technique lessens hospital stay for a patient, less blood loss and most importantly leaves no scar on the patient's body. This technique provides less complications compared to the traditional way," says Dr Manohar.

The 72-year-old man Sanaj Nambiar (name changed) from Calicut was in immense pain due to enlarged prostate for over a decade. He was going through severe difficulties including pain while urinating, difficulty in walking and imbalance.  While the normal size of the prostate gland is 15-20 gms, Nambiar was detected with 350 gm, which is unheard of in medical history.

The heavy prostrate made it difficult for Nambiar to carry out basic and normal activities of life. In addition, his kidneys were swollen due to obstruction by the grossly enlarged prostate. The family visited many hospitals and doctors in Kerala before deciding to get him treated at Bangalore. The abnormal size of the prostrate made many hospitals even in Bangalore apprehensive about conducting the critical surgery as the regular surgical process would cause bleeding and chances of its incomplete removal.

Finally, a family member recommended CARHY, which is known for its advanced technologies and expertise in the field of Urology.

His enlarged gland was removed in less than 2 hours of time without any blood loss. Nambiar was discharged from the hospital the next day. Today, he is leading a normal and active life without any complications.

About HOLEP

Holmium Laser Enucleation of the Prostate  is a laser technology to treat any kind of prostate enlargement, be it small to large. Normally, prostate enlargement is treated by conventional TURP, which has much more recurrence and bleeding during operation and excess bleeding when dealing with patients who are on blood thinning agents. HOLEP as a technology is very versatile in treating large prostate especially the ones that weigh more than 70 gms, wherein other technologies are met with complications.

Very few hospitals have such advanced technologies and the expertise to treat urological disorders. CARHY in Bangalore is one among the few leading centers in India and abroad.  Dr. Manohar, CARHY is the only surgeon in the whole of South India to have the skills and the necessary expertise to conduct surgeries through this latest technology. He has got experience to treat kidney stones, various cancers and prostate diseases through the latest LASER technologies.

About Columbia Asia Hospitals Pvt. Ltd

Columbia Asia Hospitals Pvt. Ltd. is one of the first healthcare companies to enter the country through 100% foreign direct investment (FDI) route.

About Columbia Asia Group of Companies

The Columbia Asia Group is owned by more than 150 private equity companies, fund management organizations and individual investors. The group currently operates six multi-specialty community hospitals, one referral hospital and one clinic in India. The company also operates hospitals in Malaysia (10), Vietnam (3), and Indonesia (1). The Indian management operations are managed from its office in Bangalore. For more information, visit www.columbiaasia.com

Primary Media Contact: Kanchana Prasad , kanchana.prasad@columbiaasia.com, 91-80-41201000


'/>"/>

SOURCE Columbia Asia Hospitals Pvt Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. What Can Healthcare Professionals Learn from Art? A Columbia University Physician Finds Answers at the Met
2. Cochlear Implants and BAHA Surgery at Columbia Asia Hospitals
3. Trovagene and Barretos Cancer Hospital, Brazil, to Evaluate Urine-Based HPV Assay as Potential Pap Smear Replacement
4. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
5. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
6. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
9. Gateway Unites Medicine and Therapy to Treat Drug Addiction
10. New Analysis Shows Age has a Significant Effect on Outcomes in Patients Being Treated for Clostridium difficile Infection (CDI)
11. Now Available in South Florida: CentraSight Treatment Program Offers New Hope for Patients with End-Stage Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017 Research and Markets ... Emerging Medical Device Technologies" report to their offering. ... Traditional ... procedures, general instruments, non-drug coated implantables, large endoscopes, needle based ... use over the last two to three decades for the ...
(Date:2/16/2017)... Ontario , Feb. 16, 2017  Aralez Pharmaceuticals ... global specialty pharmaceutical company, today announced that executive management ... Conference to be held February 22-23, 2017. Adrian ... of the Company at 1:35 p.m. local time on ... and audio archive for the event may be accessed ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that Vincent J. Angotti ... a member of the company,s board of directors, ... over two decades of experience leading executive and ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... ... Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. ... distinguish between corrective action (CA) and preventive action (PA)? , The methods share ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... GA (PRWEB) , ... February 17, 2017 , ... Like ... to reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), ... been a key focus area for hospitals across the nation. While many providers are ...
(Date:2/16/2017)... York, New York (PRWEB) , ... February 17, ... ... work and determination. After what took over 10 years of research, development and ... technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ingredients ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
Breaking Medicine News(10 mins):